Uncategorized

Pharmaniaga: investors should not buy it


Koon Yew Yin 23 July 2020

The price chart shows that it has shot up from Rm 2.80 to Rm 5.28 in the last 3 trading days, an increase of Rm 2.48. In its latest quarter ending 31 March 2020 the company only made EPS of 8.57 sen. Last year the company lost 57.18 sen per share. 

[ Visit TheFinancialDB.com - The Easy Way to Read Financial News - Read. Research. Profit ]

Many stupid investors chase to buy it aggressively in anticipation of the discovery of a vaccine to prevent coronavirus. Many scientists said that it will take 12-18 months to make sure that the vaccine can really work on human. In any case, Pharmaniaga is only an agent to sell medicine and not an inventor of a vaccine.     



Most Popular

To Top